Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed optimally titrated pramipexole, with significantly reduced sleep-related and dopaminergic side effectsData analysis also confirmed patients treated with P2B001 developed significantly less new-onset excessive daytime sleepiness when compared to marketed pramipexole
Pharma Two B to Present Additional Positi... - Cure Parkinson's
Pharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual Meeting
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Written by
![Farooqji profile image](https://images.hu-production.be/avatars/d2bcede6695608a9d172b4c00f6b376c_small@2x_100x100.jpg)
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Benfotiamine In The Mix For PD Again?
< 0.001) when compared with the BFT per se; (p < 0.001) when compared with the low dose of BFT; (p...
Anyone else trying ibogaine?
I started a low dose regime of ibogaine a few days ago and the results are remarkable in just a few...
Parkinson’s and vagal nerve stimulation, promising human studies.
RESULTS: PD patients showed instable gait with insufficient range of motion during usual walking....
Finding the Right Dose of Levodopa
to C/L, I am taking ¼ pramipexole 0.25 in the morning plus another ½ pramipexole at night. Any...
Another Potential Benefit Of Melatonin for PwP
of cataract compared with the general older population, which if left untreated can result in poor...